US Patent

US8480631 — Hazardous agent injection system

Method of Use · Assigned to Antares Pharma Inc · Expires 2030-03-19 · 4y remaining

Vulnerability score 73/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a hazardous agent injection system for delivering methotrexate.

USPTO Abstract

A hazardous agent injection system including from about 0.02 ml to about 4.0 ml of methotrexate at a concentration of from about 7.5 mg/ml to about 150 mg/ml; a needle-assisted jet injector including a container configured to contain the methotrexate; a injection outlet member associated with the container; an injection-assisting needle coupled to the injection outlet member; a firing mechanism associated with the container; an energy source associated with the firing mechanism; and a trigger mechanism associated with the firing mechanism, wherein the needle-assisted jet injector is configured to eject the methotrexate from the injection outlet member such that the C max , T max and bioavailability of the needle-assisted jet injected methotrexate falls between about 80% and about 125% of the C max , T max and bioavailability of methotrexate delivered by a hand-powered syringe.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259
U-1442 chembl-chembl34259

Patent Metadata

Patent number
US8480631
Jurisdiction
US
Classification
Method of Use
Expires
2030-03-19
Drug substance claim
No
Drug product claim
Yes
Assignee
Antares Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.